Rakovina Therapeutics committed to advancing new cancer therapies

Rakovina Therapeutics Inc. (TSXV:RKV), a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies, presented at the American Association of Cancer Research Annual Meeting.
The AACR Annual Meeting, held from April 8th to 13th in New Orleans, is the focal point of the cancer research community, where scientists, clinicians, other health care professionals, survivors, patients, and advocates gather to share the latest advances in cancer science and medicine.

#rakovinatherapeutics #biophrarmaceutical. #healthcare #cancertheries

video news alertinvestmentpitchinvestmentpitch media